Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CAD
The 2 analysts offering 12 month price targets for Immunoprecise Antibodies Ltd have a median target of 6.02, with a high estimate of 9.03 and a low estimate of 3.01. The median estimate represents a 791.58% increase from the last price of 0.675.
High | 1,237.4% | 9.03 |
Med | 791.6% | 6.02 |
Low | 345.8% | 3.01 |
Earnings history & estimates in CAD
The next earnings announcement is expected on Dec 12, 2024.
Average growth rate | -4.45% |
Average growth rate | +56.07% |
More ▼
Revenue history & estimates in CAD
Average growth rate | -1.35% |
Average growth rate | +12.67% |
More ▼